These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27056594)

  • 1. Improving Patient Experience With Insulin Infusion Sets: Practical Guidelines and Future Directions.
    Evert AB; Bode BW; Buckingham BA; Nardacci E; Verderese CA; Wolff-McDonagh P; Walsh J; Hirsch IB
    Diabetes Educ; 2016 Aug; 42(4):470-84. PubMed ID: 27056594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin Infusion Set Use: European Perspectives and Recommendations.
    Deiss D; Adolfsson P; Alkemade-van Zomeren M; Bolli GB; Charpentier G; Cobelli C; Danne T; Girelli A; Mueller H; Verderese CA; Renard E
    Diabetes Technol Ther; 2016 Sep; 18(9):517-24. PubMed ID: 27526329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexplained hyperglycemia in continuous subcutaneous insulin infusion: evaluation and treatment.
    Ponder SW; Skyler JS; Kruger DF; Matheson D; Brown BW
    Diabetes Educ; 2008; 34(2):327-33. PubMed ID: 18375782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetologia; 2015 May; 58(5):862-70. PubMed ID: 25784563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-hospital management of adults using insulin pump therapy.
    Houlden RL; Moore S
    Can J Diabetes; 2014 Apr; 38(2):126-33. PubMed ID: 24690507
    [No Abstract]   [Full Text] [Related]  

  • 6. Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes.
    Cescon M; DeSalvo DJ; Ly TT; Maahs DM; Messer LH; Buckingham BA; Doyle FJ; Dassau E
    J Diabetes Sci Technol; 2016 Nov; 10(6):1268-1276. PubMed ID: 27621142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel approach to preventing diabetic ketoacidosis in a patient treated with an insulin pump.
    Phillips BD; Aurand LA; Bedwell MM; Levy JR
    Diabetes Care; 2003 Oct; 26(10):2960-1. PubMed ID: 14514614
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life.
    Freckmann G; Arndt S; Fießelmann A; Klausmann G; Pralle K; Künsting T; Petersen B
    J Diabetes Sci Technol; 2017 Mar; 11(2):253-259. PubMed ID: 27605591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion.
    Heinemann L; Krinelke L
    J Diabetes Sci Technol; 2012 Jul; 6(4):954-64. PubMed ID: 22920824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing insulin pump therapy: a quality improvement project.
    Meade LT; Rushton WE
    Diabetes Educ; 2013; 39(6):841-7. PubMed ID: 24045332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current management of diabetes mellitus and future directions in care.
    Chatterjee S; Davies MJ
    Postgrad Med J; 2015 Nov; 91(1081):612-21. PubMed ID: 26453594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue Response to Subcutaneous Infusion Catheter.
    Zhang E; Cao Z
    J Diabetes Sci Technol; 2020 Mar; 14(2):226-232. PubMed ID: 30931603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Insulin Infusion Set in the New Era of Automated Insulin Delivery: A Systematic Review.
    Zhang G; Romo-Anselmo E; Kwa T; Cohen O; Vigersky R; Chattaraj S
    J Diabetes Sci Technol; 2023 Mar; 17(2):302-313. PubMed ID: 36562593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging diabetes therapies and technologies.
    Moser EG; Morris AA; Garg SK
    Diabetes Res Clin Pract; 2012 Jul; 97(1):16-26. PubMed ID: 22381908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Insulin Pump Infusion Sets Symposium Report.
    Zhang JY; Shang T; Chattaraj S; Cohen O; Heschel M; Vigersky RA; Heinemann L; Nørgaard K; Svensson J; Buckingham B; Klonoff DC
    J Diabetes Sci Technol; 2021 May; 15(3):705-709. PubMed ID: 33703930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin therapy: optimizing control in type 1 and type 2 diabetes.
    Rosenstock J
    Clin Cornerstone; 2001; 4(2):50-64. PubMed ID: 11838327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramadan Prospective Diabetes Study: the role of drug dosage and timing alteration, active glucose monitoring and patient education.
    Ahmedani MY; Haque MS; Basit A; Fawwad A; Alvi SF
    Diabet Med; 2012 Jun; 29(6):709-15. PubMed ID: 22587405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbidity and mortality of diabetic ketoacidosis with and without insulin pump care.
    Realsen J; Goettle H; Chase HP
    Diabetes Technol Ther; 2012 Dec; 14(12):1149-54. PubMed ID: 23009106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.